PSQH: The Podcast Episode 5 – Using AI to Reduce Opioid Use During Surgery
On episode 5 of PSQH: The Podcast, host Jay Kumar talks to Greg Latham, attending anesthesiologist at Seattle Children’s Hospital, and Dan Low, chief medical officer of MDmetrix, about the use of AI to reduce opioid use during surgeries to keep pediatric patients safe.
Q&A: Many Hospitals Still Don’t Have Drug Diversion Programs
The Porter Research survey commissioned by Invistics found that nine out of 10 surveyed believe their facility’s drug diversion program is the same or even better than other organizations, and two out of three are confident or very confident that their drug diversion program successfully identifies employees who divert drugs. But there is definitely a disconnect, because 70% of participants said they believe most diversion incidents in the U.S. go undetected.
EHRs Fail to Detect Up to One-third of Medication Errors
Researchers at the University of Utah Health, Harvard University, and Brigham and Women’s Hospital in Boston found that the most commonly used EHRs in hospitals across the nation fail to detect up to 33% of potentially dangerous drug interactions and other medication errors that could harm or kill patients.
NIOSH Seeks Comment on Updated List of Hazardous Drugs in Healthcare
The proposal includes a name change and reorganization of drug lists so that not all antineoplastic drugs, most often associated with cancer treatments, are grouped together. Formerly the “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings,” the list will be called more simply the “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020.”
Over-the-Top Risky: Overuse of ADC Overrides, Removal of Drugs Without an Order, and Use of Non-Profiled Cabinets
Whether used as a full decentralized drug distribution model or for limited distribution of controlled substances, PRN (as needed) medications, and first doses only, ADCs today are often interfaced with electronic health record systems in both large and small healthcare settings.
Survey Highlights Pervasive Drug Diversion Problem in U.S. Hospitals
The survey found that 86% surveyed have met or know someone who has diverted drugs, with another 43% indicating their facility could be at risk of fines, bad publicity, lawsuits, or overdoses because of past or potential drug diversion cases.
Network Seeks to Reduce Drug Diversion, Increase Reporting Rate
So far, the network has tracked drug diversion at 90 hospitals, 28 nursing homes, and dozens of other types of healthcare facilities, including ambulatory surgical centers, assisted living centers, clinics, compounding pharmacies, medical laboratories, mental health facilities, pain clinics, rehabilitation homes, retail pharmacies, and schools.
A Lot Happens When You Report a Hazard or Error to ISMP—There’s No ‘Black Hole’ Here!
When ISMP receives a hazard or error report, it is entered into one of our databases and initially reviewed by an ISMP nurse or pharmacy technician analyst. Since most reports submitted to ISMP include the reporter’s email address, ISMP sends an email to the reporter to confirm receipt of the report and to thank him or her for reporting.
Full Transparency Is the Key to Stopping Drug Diversion in Healthcare Settings
Drug diversion costs the healthcare industry more than $70 billion per year, according to one estimate, and some researchers say as many as 10% of all medical professionals will divert drugs from their workplace at some point in their career.
Medicaid Expansion Linked to Fewer Opioid Deaths
Researchers NYU Grossman School of Medicine and University of California, Davis, analyzed cause-of-death data from the National Vital Statistics System from 3,109 counties nationwide between 2001 and 2017.